A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders - Wikidata - wikimedia - TriplyDB

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders

http://www.wikidata.org/entity/Q33690844

about

Autism spectrum disorder in adults: diagnosis, management, and health services development New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences A review of rhythm and responsiveness of cortisol in individuals with autism spectrum disorders Mental health services for individuals with high functioning autism spectrum disorder Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders A descriptive social and health profile of a community sample of adults and adolescents with Asperger syndrome.Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.Psychiatric comorbidity and medication use in adults with autism spectrum disorder.Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey Change in the Behavioral Phenotype of Adolescents and Adults with FXS: Role of the Family Environment Trajectories of internalizing and externalizing symptoms among adults with autism spectrum disorders.Emergency Department Use Among Adults with Autism Spectrum Disorders (ASD).Prevalence and Predictors of Psychotropic Use in Children with High-Functioning ASDs.Atypical lateralization of motor circuit functional connectivity in children with autism is associated with motor deficits Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.Planning Skills in Autism Spectrum Disorder Across the Lifespan: A Meta-analysis and Meta-regression.A systematic review of psychosocial interventions for adults with autism spectrum disorders.Autism spectrum disorders: an overview on diagnosis and treatment.The use of antipsychotics in preschoolers: a veto or a sensible last option?Brief Report: Understanding Crisis Behaviors in Hospitalized Psychiatric Patients with Autism Spectrum Disorder--Iceberg Assessment Interview.A Scoping Review of Health Disparities in Autism Spectrum Disorder.Mass spectrometric evaluation of neurotransmitter levels in IMR 32 cell line in response to Ayurvedic medicines.Physical Activity, Screen-Time Behavior, and Obesity Among 13-Year Olds in Ireland with and without Autism Spectrum Disorder.Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders.Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders.Use of Sleep Evaluations and Treatments in Children with Down Syndrome.Intellectual developmental disorder in adult psychiatry: A 24-year register study.Subregional differences in intrinsic amygdala hyperconnectivity and hypoconnectivity in autism spectrum disorder.Trajectories, Long-Term Outcomes and Family Experiences of 76 Adults with Autism Spectrum Disorder.Self and informant reports of mental health difficulties among adults with autism findings from a long-term follow-up study.Training of child and adolescent psychiatry fellows in autism and intellectual disability.Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.The missing link: delayed emotional development predicts challenging behavior in adults with intellectual disability.

P2860

Q26741443-EB33FAC2-D2D0-4B97-ACB4-9096A8E35506 Q26771762-DA6922F7-0D00-40E5-9FE5-4AC91E828163 Q26823076-6A1CDD37-05AD-4203-A9EC-11C999334F21 Q26828583-A3C81994-C753-4C26-8986-9D22C036209F Q33664787-E5291E62-5E52-45D4-949A-615CDB16AC08 Q33744556-FE919828-3655-4210-8123-92A850CD3FFE Q34424843-A1F19CFF-7436-4A7B-94FB-EC4EB7F03175 Q34426226-465E6D28-B68F-44E0-B96A-6357EEF484D1 Q35178499-1211518D-8906-4534-A7E7-33CB217918C1 Q35619221-83AF56C4-37C6-4C23-9661-01C0EA416042 Q35641660-7B4CA4CE-0FCA-4EBB-B420-523353CC36AC Q35757716-23D5F920-41D4-4674-BFBF-9428180CB0E4 Q35899465-739518A3-4E30-4BB7-9DEB-99BE8A10C67F Q36703079-60914409-6532-4622-87F7-739E9643E434 Q36784495-D1D7DC54-2963-4A67-9B51-C67A26446E4F Q36788588-9FB4CE4E-F206-4CB4-A6DD-8C1E1CD45F88 Q36835688-00861699-E543-4A8C-9CF8-6333F2045F44 Q36898576-DEE5C251-ABC3-46A9-9DED-85CA5C895D1B Q37096854-9FA2B0FB-9929-4649-A164-5C347A25F1A6 Q37452761-3531AAFB-CE08-4F8E-8A08-585A1211578D Q37598430-73525C00-E208-4A5D-95F4-9AAFD39FCBAA Q37709982-91CE91DD-8689-451B-8B91-12973A13CA2A Q38028879-473E24AC-15C7-4FE7-A7FD-46E3AAC7A2A6 Q38154183-85687F69-1520-4F04-AC6F-385DCC1878BE Q38180865-7BAA3C47-DDFD-4F67-9399-682C8FD74296 Q38577669-0D7E1C27-BFD2-45C5-BB0F-723B611B5C9D Q38649757-5E69584B-A2F5-4AD1-83D1-D2DA978930A4 Q38769865-AD37D2FA-5297-4EE0-BD4B-93772ADCC979 Q38817377-9F316FED-4B1A-4FC3-95B6-18380D6BFBEC Q38889269-0786ACE7-0175-473C-BD47-D95D74782EE3 Q38953538-DA59C7E5-82EA-4EF7-BD0D-B0D39253CBF9 Q39163633-9CA10B6B-F2F9-4AE9-B147-E1396160C6BF Q39473601-20DAD64F-989B-4C42-A7FE-2ADAFF22401C Q39813042-2EBEE215-F0CA-48B5-97DE-60F9FE3A5109 Q40212963-34FF98D4-5267-4D1F-AF7A-BCD47E94CA5E Q40317970-3BF7C2E8-E127-4C49-B2A1-514A351AC126 Q40898873-9970C69A-6AF8-4847-A98D-22439CDC3967 Q40989148-B807A2E8-B165-4420-8123-1446E14238DE Q45298736-6FD6F185-2C1A-4649-BA2A-6B0DC0FBA769 Q47288481-D8CD3B05-B8EE-4715-A691-BE4D1114B2D4

P2860

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders

http://www.wikidata.org/entity/Q33690844

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A longitudinal investigation o ...... with autism spectrum disorders

@ast

A longitudinal investigation o ...... with autism spectrum disorders

@en

type

label

A longitudinal investigation o ...... with autism spectrum disorders

@ast

A longitudinal investigation o ...... with autism spectrum disorders

@en

prefLabel

A longitudinal investigation o ...... with autism spectrum disorders

@ast

A longitudinal investigation o ...... with autism spectrum disorders

@en

P1433

Q33690844-B18AD878-65BC-429F-A8DA-455BE20E4C45

P1476

Q33690844-04B3B46E-D198-4276-A458-5A08F8E2C7B7

P2093

Q33690844-0EC0ABDB-798E-4485-8FA0-C74762E5CE8B

Q33690844-2F7324F5-2638-4A47-BA23-66D99161B942

Q33690844-69026BF9-9C76-4531-A3C6-33C53F403A6A

P2860

Q33690844-002BEC04-DFAE-4BF7-B102-12017A0B7B28

Q33690844-07D3202E-2E73-4AA4-B188-B4B31C6459FC

Q33690844-10C34126-73F0-4815-B2E6-CD25702D7920

Q33690844-12704767-32D8-4E8B-BCF9-28A5FAC8E22C

Q33690844-15D5534E-C993-40C0-B2CA-367DB77EADCE

Q33690844-16EE91FA-7AB7-4D05-AB73-039A64419DDB

Q33690844-1ACEF08F-CC60-4F3C-95BE-6B8E4EAEB29D

Q33690844-1DBF4D6A-2F8E-4D5A-A1F4-1C2BBC336125

Q33690844-34215AAF-37E1-44D3-8B83-D758A0B9C36E

Q33690844-3AA5A8A8-4F8D-455F-AE7B-D9835C3094D3

P2888

Q33690844-1CD1B28D-6824-4629-A430-C03E34701132

P304

Q33690844-2A211C65-2A58-4DA9-9679-ED2D2233C1F7

P31

Q33690844-F6FAD8F6-A68C-4BC3-8288-99BD00ABE0D9

P356

Q33690844-2A8C6806-0FF4-431A-A4F9-05648F94657C

P407

Q33690844-9FBB7A79-A0CC-4BE2-B46A-4FAE66661DDB

P433

Q33690844-6339D8D4-F49D-4E14-BFB9-58C097C7E9D9

P478

Q33690844-DCFEE0AD-4F09-4982-94EA-876F5750FF96

P50

Q33690844-8715076B-B3B0-4BC7-B8C5-25210FC5E2CC

P577

Q33690844-7709EE09-CDDA-4EEE-AB86-60C95C49C434

P5875

Q33690844-AFAACC14-E5C2-457A-90D6-90A9B30A9FB2

P6179

Q33690844-46E73BBC-D7AA-4144-A3A1-F97C385A5560

P698

Q33690844-7D4DBE09-F229-4F6C-9745-3CFD41E74FB9

P921

Q33690844-84EF2C42-161D-4CCA-A64A-5774091F054F

Q33690844-A033959C-3CC4-4FDC-892A-362B7D75DA65

P932

Q33690844-9FFDF5A2-9995-434B-9B43-77222CB634A1

P356

S10803-009-0750-3

P1433

Journal of Autism and Developmental Disorders

P1476

A longitudinal investigation o ...... with autism spectrum disorders

@en

P2093

Anna J Esbensen

http://www.w3.org/2001/XMLSchema#string

Jan S Greenberg

http://www.w3.org/2001/XMLSchema#string

Michael G Aman

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder

Antipsychotics in the treatment of autism

The status of pharmacotherapy for autism spectrum disorders

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders.

Risperidone in children with autism and serious behavioral problems.

Epilepsy in autism spectrum disorders.

The use of selective serotonin reuptake inhibitors in autism and related disorders.

A developmental psychopathology perspective on adolescence.

P2888

s10803-009-0750-3

P304

1339-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10803-009-0750-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Marsha Mailick Seltzer

P577

2009-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24419941

http://www.w3.org/2001/XMLSchema#string

P6179

1011258266

http://www.w3.org/2001/XMLSchema#string

P698

19434487

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

P932

2829244

http://www.w3.org/2001/XMLSchema#string